Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate

Ann Hematol. 2022 Aug;101(8):1885-1886. doi: 10.1007/s00277-022-04839-2. Epub 2022 Apr 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Glatiramer Acetate / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / drug therapy
  • Peptides / therapeutic use
  • Polycythemia Vera* / complications
  • Polycythemia Vera* / drug therapy

Substances

  • Immunosuppressive Agents
  • Peptides
  • Glatiramer Acetate